LGND
Ligand Pharmaceuticals Incorporated
301.80$
+2.3%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +76.6% | -23.4% | -4.3% | +19.2% | +51.2% | +11.3% | +60.3% | -49.3% | +30.5% | -27.0% | -42.5% | -0.7% | +8.8% | +22.8% | +24.9% | +1.0% | +67.2% | -21.2% | +53.5% | -23.4% | +11.8% | -49.6% | +37.3% | +18.1% | -54.3% | +62.6% | -40.0% | +24.7% | -14.5% | +10.2% | +34.1% | +24.8% | -17.4% | +5.9% | +5.1% | +142.4% | -48.3% | -13.3% | +23.1% | – | |
| – | +189.9% | -88.2% | +164.8% | +164.1% | -27.1% | -54.7% | +43.9% | +28.7% | +102.4% | +30.6% | -37.7% | +30.9% | -38.4% | +141.8% | +63.2% | -16.9% | +84.8% | -30.5% | +275.2% | -62.6% | +4.7% | -60.8% | +163.1% | +14.5% | +52.7% | -82.8% | -55.1% | +108.8% | -52.3% | +565.1% | -238.5% | – | -77.3% | +70.9% | -40.0% | +753.8% | -204.7% | – | +54.9% | – | |
| – | +71.1% | -18.0% | -6.3% | +14.4% | +57.2% | +13.6% | +60.6% | -50.3% | +28.1% | -30.0% | -43.0% | -4.1% | +15.7% | +13.6% | +18.6% | +5.1% | +64.1% | -19.3% | +15.1% | -1.3% | +13.3% | -47.4% | +18.7% | +19.3% | -87.9% | +641.3% | -38.7% | +19.0% | -10.0% | -24.7% | +185.6% | -30.8% | +1.7% | +1.3% | +10.5% | +102.7% | -5.5% | -42.0% | +21.8% | – | |
| – | +1.6% | +35.3% | -44.4% | -1.3% | +81.4% | -14.2% | -17.2% | -10.6% | +61.2% | +27.7% | +8.2% | +12.5% | +35.8% | -36.3% | +7.1% | +1.0% | +70.5% | -18.4% | -10.8% | +6.2% | +7.7% | -49.7% | -7.8% | +9.1% | +174.7% | -73.7% | +2.9% | -19.3% | -0.8% | +8.8% | -10.3% | +6.0% | -22.0% | +1,031.9% | -86.9% | +220.1% | -83.3% | -38.8% | +582.9% | – | |
| – | +5.1% | +10.5% | -10.6% | +7.4% | +10.2% | -1.4% | +21.6% | +3.6% | +15.9% | -0.7% | -0.8% | -13.4% | +7.9% | -9.9% | +8.7% | +49.2% | +100.3% | -58.1% | +16.6% | -13.5% | +39.5% | -32.8% | +1.4% | +23.4% | +33.1% | -45.3% | +4.0% | +29.8% | +9.1% | -31.5% | +60.9% | +38.9% | +4.6% | -26.6% | +7.3% | +41.0% | -12.0% | -16.7% | +39.8% | – | |
| – | +5.7% | +18.7% | -24.8% | +3.0% | +40.6% | -10.1% | +2.2% | +11.2% | +12.7% | +10.2% | +3.2% | +0.4% | +31.4% | -29.9% | +8.0% | +19.0% | +48.2% | -10.1% | -80.3% | +351.7% | +26.7% | -37.8% | -2.0% | +12.5% | -120.6% | – | +2.4% | -1.4% | +13.3% | -43.2% | +348.9% | -52.4% | +37.1% | +54.6% | -52.7% | -1.6% | +83.7% | -50.8% | +60.7% | – | |
| – | +254.1% | -47.2% | +27.4% | +26.7% | +71.9% | +30.7% | +89.5% | -66.7% | +41.9% | +2,393.4% | -100.5% | – | – | – | +87.4% | -47.2% | +199.2% | -57.9% | +870.1% | -65.7% | -18.9% | -83.2% | +306.1% | +42.5% | -1.3% | +16.7% | -114.0% | – | -209.1% | – | -739.2% | – | -406.6% | – | – | +550.5% | -63.5% | -13.3% | -50.5% | – | |
| – | -3.5% | -2.2% | +13.6% | +1.3% | -18.0% | +25.4% | +286.6% | -16.8% | +79.8% | -55.8% | +1.2% | -0.2% | -1.8% | -3.2% | -27.3% | +0.9% | +1.9% | -8.7% | -16.3% | -9.1% | +0.7% | -82.4% | -44.5% | -24.2% | -27.7% | +0.0% | +18.3% | -99.6% | +13,000.0% | +7.6% | +799.3% | -41.6% | +19.2% | -1.8% | +33.0% | -21.1% | +96.2% | -2.1% | +0.1% | – | |
| – | +799.3% | -14.3% | +34.0% | +45.4% | +154.0% | +80.4% | +72.8% | -17.1% | -171.7% | – | -102.1% | – | – | – | – | -141.3% | – | +71.0% | +477.7% | -54.2% | -146.0% | – | – | +42.6% | +352.7% | -0.7% | -94.3% | -483.0% | – | +563.5% | -157.6% | – | – | – | – | +1,157.6% | -59.8% | -142.7% | – | – | |
| – | +6,371.9% | -89.2% | +101.3% | +62.6% | +933.6% | -73.4% | +123.5% | -47.1% | -220.6% | – | -102.0% | – | – | – | – | -181.4% | – | – | – | -40.4% | -204.8% | – | -204.0% | – | +1,571.2% | -73.7% | -92.6% | -312.4% | – | – | -149.4% | – | -1,073.8% | – | – | +274.3% | -49.7% | -191.0% | – | – | |
| – | -585.2% | – | +19.3% | +39.1% | -183.2% | – | +61.6% | -7.9% | -163.1% | – | -102.2% | – | – | – | – | -130.3% | – | +214.3% | +69.7% | -55.3% | -139.5% | – | – | – | -4,428.0% | – | -94.5% | -548.6% | – | +373.6% | -160.3% | – | – | – | – | +2,319.5% | -61.8% | -129.8% | – | – | |
| – | +165.8% | -40.9% | +18.2% | +12.8% | +84.6% | +88.4% | +83.6% | -14.4% | -134.5% | – | -110.7% | – | – | -168.2% | – | -102.1% | – | +9.4% | -3.1% | +2.5% | -57.6% | -49.1% | +319.5% | +18.1% | +157.0% | -2.9% | -80.2% | -127.3% | – | +367.9% | -145.2% | – | -974.3% | – | – | +614.9% | -55.6% | -121.5% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.